Leticia Poret
Internal Medicine · San Antonio, TXNPI 1578763462
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 519 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $2,356 and has fallen 94.6% since, to $128 in 2025. Among internal medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 519 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$1K
- GSK$1K
- Lilly USA, LLC$1K
- Boehringer Ingelheim$824
- Pfizer$615
- plus $2K from 23 others
What the payments were for
- Food & beverage$8,749100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 81 | $1,520 |
| Novo Nordisk | 74 | $1,297 |
| GSK | 80 | $1,295 |
| Lilly USA, LLC | 58 | $1,078 |
| Boehringer Ingelheim | 53 | $824 |
| Pfizer | 47 | $615 |
| Amarin Pharma, Inc. | 30 | $463 |
| Johnson & Johnson | 20 | $325 |
| Esperion Therapeutics, Inc. | 13 | $220 |
| Amgen | 12 | $201 |
| Abbott | 7 | $153 |
| Astellas Pharma US Inc | 6 | $128 |
| AbbVie(2 entities) | 6 | $114 |
| Novartis | 4 | $63 |
| Bayer | 3 | $59 |
| Sanofi-aventis U.S. LLC | 3 | $52 |
| Sunovion Pharmaceuticals Inc. | 4 | $51 |
| Bausch Health US, LLC | 3 | $42 |
| Kowa Pharmaceuticals America, Inc. | 3 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Genentech USA, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Merck | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Tactile Systems Technology Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,749 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $82 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in San Antonio
- Manuel RodriguezSan Antonio$263K
- Matthew CatesSan Antonio$248K
- Fabian Rodas OchoaSan Antonio$68K
- Darius BuzenasSan Antonio$49K
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.